| The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1 CL Bevan, S Hoare, F Claessens, DM Heery, MG Parker Molecular and cellular biology, 1999 | 519 | 1999 |
| Impact of analytical bias in metabonomic studies of human blood serum and plasma O Teahan, S Gamble, E Holmes, J Waxman, JK Nicholson, C Bevan, ... Analytical chemistry 78 (13), 4307-4318, 2006 | 305 | 2006 |
| Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination H Huang, LL Benzonana, H Zhao, HR Watts, NJS Perry, C Bevan, ... British journal of cancer 111 (7), 1338-1349, 2014 | 246 | 2014 |
| The role of androgen receptor mutations in prostate cancer progression GN Brooke, CL Bevan Current genomics 10 (1), 18-25, 2009 | 225 | 2009 |
| Circulating microRNAs as potential new biomarkers for prostate cancer A Sita-Lumsden, DA Dart, J Waxman, CL Bevan British journal of cancer 108 (10), 1925-1930, 2013 | 181 | 2013 |
| Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer CE Fletcher, DA Dart, A Sita-Lumsden, H Cheng, PS Rennie, CL Bevan Human molecular genetics 21 (14), 3112-3127, 2012 | 169 | 2012 |
| Hey1, a mediator of notch signaling, is an androgen receptor corepressor B Belandia, SM Powell, JM García-Pedrero, MM Walker, CL Bevan, ... Molecular and cellular biology, 2005 | 154 | 2005 |
| Androgens target prohibitin to regulate proliferation of prostate cancer cells SC Gamble, M Odontiadis, J Waxman, JA Westbrook, MJ Dunn, R Wait, ... Oncogene 23 (17), 2996-3004, 2004 | 153 | 2004 |
| Analysis of the steroid receptor coactivator 1 (SRC1)-CREB binding protein interaction interface and its importance for the function of SRC1 HM Sheppard, JC Harries, S Hussain, C Bevan, DM Heery Molecular and cellular biology, 2001 | 131 | 2001 |
| Visualising androgen receptor activity in male and female mice DA Dart, J Waxman, EO Aboagye, CL Bevan PloS one 8 (8), e71694, 2013 | 128 | 2013 |
| Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate. SM Powell, V Christiaens, D Voulgaraki, J Waxman, F Claessens, ... Endocrine-related cancer 11 (1), 117-130, 2004 | 125 | 2004 |
| Role of androgen receptor variants in prostate cancer: report from the 2017 mission androgen receptor variants meeting J Luo, G Attard, SP Balk, C Bevan, K Burnstein, L Cato, A Cherkasov, ... European urology 73 (5), 715-723, 2018 | 124 | 2018 |
| Light-triggered enzymatic reactions in nested vesicle reactors JW Hindley, Y Elani, CM McGilvery, S Ali, CL Bevan, RV Law, O Ces Nature communications 9 (1), 1093, 2018 | 123 | 2018 |
| Single-molecule amplification-free multiplexed detection of circulating microRNA cancer biomarkers from serum S Cai, T Pataillot-Meakin, A Shibakawa, R Ren, CL Bevan, S Ladame, ... Nature Communications 12 (1), 3515, 2021 | 116 | 2021 |
| Building a synthetic mechanosensitive signaling pathway in compartmentalized artificial cells JW Hindley, DG Zheleva, Y Elani, K Charalambous, LMC Barter, PJ Booth, ... Proceedings of the National Academy of Sciences 116 (34), 16711-16716, 2019 | 114 | 2019 |
| Revising the role of the androgen receptor in breast cancer FM Fioretti, A Sita-Lumsden, CL Bevan, GN Brooke Journal of molecular endocrinology 52 (3), R257-R265, 2014 | 113 | 2014 |
| Characterization of the two coactivator-interacting surfaces of the androgen receptor and their relative role in transcriptional control V Christiaens, CL Bevan, L Callewaert, A Haelens, G Verrijdt, ... Journal of Biological Chemistry 277 (51), 49230-49237, 2002 | 108 | 2002 |
| Prohibitin, a protein downregulated by androgens, represses androgen receptor activity SC Gamble, D Chotai, M Odontiadis, DA Dart, GN Brooke, SM Powell, ... Oncogene 26 (12), 1757-1768, 2007 | 107 | 2007 |
| Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression GN Brooke, MG Parker, CL Bevan Oncogene 27 (21), 2941-2950, 2008 | 99 | 2008 |
| Mini-review: Foldosome regulation of androgen receptor action in prostate cancer LQ Cano, DN Lavery, CL Bevan Molecular and cellular endocrinology 369 (1-2), 52-62, 2013 | 88 | 2013 |
Greg BrookeSenior Lecturer in Molecular and Cellular Biology, University of EssexVerified email at essex.ac.uk
